News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
850,349 Results
Type
Article (86677)
Company Profile (703)
Press Release (762967)
Multimedia
Podcasts (137)
Webinars (17)
Section
Business (232749)
Career Advice (4129)
Deals (39738)
Drug Delivery (129)
Drug Development (91049)
Employer Resources (198)
FDA (18145)
Job Trends (17349)
News (396648)
Policy (39784)
Tag
Academia (3002)
Academic (2)
Accelerated approval (7)
Adcomms (32)
Allergies (100)
Alliances (56916)
ALS (112)
Alzheimer's disease (1532)
Antibody-drug conjugate (ADC) (181)
Approvals (18093)
Artificial intelligence (361)
Autoimmune disease (33)
Automation (18)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (124)
Biotechnology (481)
Bladder cancer (92)
Brain cancer (36)
Breast cancer (370)
Cancer (2838)
Cardiovascular disease (230)
Career advice (3536)
Career pathing (34)
CAR-T (196)
Cell therapy (541)
Cervical cancer (22)
Clinical research (73921)
Collaboration (1006)
Company closure (3)
Compensation (636)
Complete response letters (30)
COVID-19 (2892)
CRISPR (61)
C-suite (306)
Cystic fibrosis (116)
Data (2781)
Decentralized trials (2)
Denatured (48)
Depression (64)
Diabetes (322)
Diagnostics (6953)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (162)
Drug pricing (145)
Drug shortages (35)
Duchenne muscular dystrophy (119)
Earnings (97400)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131104)
Executive appointments (869)
FDA (19710)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (915)
Gene editing (138)
Generative AI (36)
Gene therapy (407)
GLP-1 (885)
Government (5201)
Grass and pollen (6)
Guidances (179)
Healthcare (20911)
Huntington's disease (29)
IgA nephropathy (39)
Immunology and inflammation (169)
Immuno-oncology (6)
Indications (35)
Infectious disease (3064)
Inflammatory bowel disease (160)
Inflation Reduction Act (12)
Influenza (63)
Intellectual property (112)
Interviews (813)
IPO (17875)
IRA (53)
Job creations (5191)
Job search strategy (2861)
Kidney cancer (15)
Labor market (51)
Layoffs (577)
Leadership (25)
Legal (10125)
Liver cancer (83)
Lung cancer (404)
Lymphoma (190)
Machine learning (9)
Management (65)
Manufacturing (401)
MASH (90)
Medical device (14679)
Medtech (14684)
Mergers & acquisitions (22511)
Metabolic disorders (862)
Multiple sclerosis (99)
NASH (23)
Neurodegenerative disease (132)
Neuropsychiatric disorders (37)
Neuroscience (2223)
NextGen: Class of 2025 (7686)
Non-profit (5087)
Now hiring (44)
Obesity (456)
Opinion (283)
Ovarian cancer (96)
Pain (111)
Pancreatic cancer (106)
Parkinson's disease (183)
Partnered (25)
Patents (284)
Patient recruitment (139)
Peanut (53)
People (65535)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22827)
Phase II (32101)
Phase III (24168)
Pipeline (1581)
Policy (206)
Postmarket research (3552)
Preclinical (10298)
Press Release (72)
Prostate cancer (136)
Psychedelics (39)
Radiopharmaceuticals (276)
Rare diseases (486)
Real estate (7397)
Recruiting (75)
Regulatory (26962)
Reports (61)
Research institute (2663)
Resumes & cover letters (649)
Rett syndrome (9)
RNA editing (9)
RSV (52)
Schizophrenia (90)
Series A (156)
Series B (105)
Service/supplier (30)
Sickle cell disease (62)
Special edition (21)
Spinal muscular atrophy (166)
Sponsored (35)
Startups (4297)
State (2)
Stomach cancer (16)
Supply chain (79)
Tariffs (62)
The Weekly (87)
Vaccines (861)
Venture capitalists (49)
Weight loss (313)
Women's health (45)
Worklife (20)
Date
Today (127)
Last 7 days (566)
Last 30 days (3055)
Last 365 days (34888)
2025 (15888)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (66)
Alaska (7)
Arizona (277)
Arkansas (14)
Asia (50367)
Australia (8854)
California (7349)
Canada (2276)
China (658)
Colorado (313)
Connecticut (327)
Delaware (186)
Europe (115547)
Florida (1080)
Georgia (249)
Hawaii (1)
Idaho (65)
Illinois (703)
India (31)
Indiana (365)
Iowa (16)
Japan (214)
Kansas (115)
Kentucky (30)
Louisiana (17)
Maine (73)
Maryland (1053)
Massachusetts (5615)
Michigan (265)
Minnesota (457)
Mississippi (3)
Missouri (95)
Montana (32)
Nebraska (26)
Nevada (79)
New Hampshire (72)
New Jersey (2042)
New Mexico (31)
New York (2060)
North Carolina (1203)
North Dakota (10)
Northern California (3171)
Ohio (242)
Oklahoma (16)
Oregon (48)
Pennsylvania (1573)
Puerto Rico (17)
Rhode Island (39)
South America (1653)
South Carolina (32)
South Dakota (1)
Southern California (2712)
Tennessee (121)
Texas (1106)
United States (27775)
Utah (217)
Virginia (196)
Washington D.C. (78)
Washington State (656)
West Virginia (4)
Wisconsin (80)
There are 850,349 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
vaccines
In ‘Bold’ Move, RFK Jr. ‘Retires’ All 17 Members of CDC’s Vaccine Committee
Two weeks of upheaval at the CDC culminated Monday in the complete reconstitution of the CDC’s Advisory Committee on Immunization Practices as HHS Secretary Robert F. Kennedy Jr. pens op-ed criticizing “conflicts of interest” he says exist on the current committee.
June 9, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Veloxity Labs Announces NIL Partnership with Bradley University Track Star Carolina Martinez
Local collaboration celebrates resilience, community and a shared commitment to saving lives.
June 9, 2025
·
1 min read
Neurodegenerative disease
Avidity’s siRNA Muscular Dystrophy Drug Improves Mobility, Boosts Muscle Strength
Avidity has been given the go-ahead by the FDA to request accelerated approval of delpacibart braxlosiran—potentially the first disease-modifying treatment for facioscapulohumeral muscular dystrophy—with an application in the second half of 2026.
June 9, 2025
·
2 min read
·
Dan Samorodnitsky
Vaccines
ACIP Members Receive Termination Notices as Fears Mount Over RFK Jr.’s Vaccine Machinations
The loss of special government employee status for four members of the CDC’s Advisory Committee on Immunization Practices follows the resignation of ACIP co-lead Lakshmi Panagiotakopoulos, who left in protest of a controversial change in COVID-19 recommendations for healthy children and pregnant women.
June 9, 2025
·
2 min read
·
Heather McKenzie
Duchenne muscular dystrophy
Keros To Return $375M to Investors After Shareholder Activism, Safety Signal
After a major shareholder pushed back, Keros is returning half of its capital to investors in a move that Guggenheim analysts called “a positive step forward.”
June 9, 2025
·
2 min read
·
Annalee Armstrong
Cardiovascular disease
Merck Moves Forward in Bid To Bring First Oral PCSK9 Inhibitor to Market
Merck’s enlicitide decanoate significantly lowered low-density lipoprotein cholesterol in two Phase III trials, unlocking what BMO Capital Markets called a “multi-billion dollar opportunity” for the pharma.
June 9, 2025
·
2 min read
·
Tristan Manalac
Weight loss
Metsera Shares Rise as Monthly Weight Loss Injection Shaves Over 8% Body Weight at 36 Weeks
In what Guggenheim Partners called one of Metsera’s “critical program milestones” this year, its ultra-long-acting amylin injection MET-233i showed promising weight-loss over about eight months.
June 9, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Medicus Pharma Ltd. Announces Submission of Product Development Plan to the Food and Drug Administration (FDA) to Treat External Squamous Cell Carcinoma (SCC) in Horses
Company Is Advancing Use of Novel Doxorubicin-containing Microneedle Array (D-MNA) Patch in Veterinary Oncology as an Orphan Drug
June 9, 2025
·
10 min read
Press Releases
Defence Therapeutics Receives USPTO Allowance for Patent Application Covering Next-Gen ADC Technology
June 9, 2025
·
3 min read
Press Releases
Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology
June 9, 2025
·
4 min read
1 of 85,035
Next
